The Federal Trade Commission wants to extract least $1B from pharmaceutical companies for their alleged efforts to thwart the entry of cheaper generic drugs by paying generic makers to delay introducing their offerings.
Last June, the U.S. Supreme Court ruled that the FTC may legally challenge the deals.
var isMC=true; var adSize=’320×50′; var ord = Math.floor(Math.random()*10e12); var seekingalpha_ad_src=’http://ad.doubleclick.net/N6001/adj/sek.mobile/app;sz=320×50,320×250;x=x;tile=1;d=mobile;t=app;mcid=true;mcid=1650323;s=NVO;s=PFE;s=SNY;s=ABBV;s=JNJ;s=RHHBY;s=GSK;s=AZN;s=BMY;’+dart_my_vocation_and_profiles()+’ord=’+ord+’;dev=ip?’; document.write(”);
March 28th, 2014 at 4:14 pm
Government agency plans to shake down Big Pharma
01:54 PM ET · NVO